戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 basal ganglia glutamate and the glial marker myoinositol.
2 ntent compared with animals not infused with myoinositol.
3 lease of osmoregulators, such as taurine and myoinositol.
4 The translated product of accG is related to myoinositol 1 (or 4) monophosphatases from various eucar
5 d SRF, connexin 43 in the cell membrane, and myoinositol 1,4,5-triphosphate receptor in the perinucle
6                                              Myoinositol 1,4,5-triphosphate receptor inhibition suppr
7                                            D-Myoinositol 1,4,5-trisphophate 3-kinases (IP(3)-3Ks) pla
8  0.0001) and >3-fold increases in cellular d-myoinositol 1,4,5-trisphosphate (Ins(1,4,5)P3) levels.
9 of a variety of second messengers, including myoinositol 1,4,5-trisphosphate [Ins(1,4,5)P(3)].
10  pathway from glucose 6-phosphate (G 6-P) to myoinositol 1-phosphate (Ins 1-P) and myo-inositol (Ins)
11 ynthesis of myoinositol and the breakdown of myoinositol (1,4,5)trisphosphate, a potent second messen
12         We have studied the expression of 1L-myoinositol-1-phosphate synthase (MIPS; EC 5.5.1.4) in d
13 identify two targets of this modification as myoinositol-1-phosphate synthase and superoxide dismutas
14 also showed enzyme activity on the substrate myoinositol-1-phosphate, indicating that the AtPAP15 is
15 rabidopsis thaliana) recombinant VTC4 with d-myoinositol 3-phosphate (d-Ins 3-P) and l-Gal 1-P.
16  adenophostin A and L-alpha-glycerophospho-D-myoinositol-4,5-bisphosphate (GPIP(2)).
17 bohydrate metabolism to enhance synthesis of myoinositol-a precursor for phosphatidylinositol biosynt
18                                              Myoinositol alone or myoinositol, betaine, and taurine g
19 iratory amino acids, glycine and serine, and myoinositol also accumulated under drought.
20 d with pro-inflammatory processes, including myoinositol and 1-methyl-histidine, by targeted mass spe
21                                Surprisingly, myoinositol and all inositol phosphates tested were perm
22 lite levels in vtc4 mutants showed that less myoinositol and ascorbate accumulate in these mutants.
23 4 is a bifunctional enzyme that impacts both myoinositol and ascorbate synthesis pathways.
24  increasing NAA and glutamate and decreasing myoinositol and choline with age.
25                            Concentrations of myoinositol and choline-containing compounds were signif
26 olyzes myoinositol hexakisphosphate to yield myoinositol and free phosphate.
27 nt correlation between levels of glycine and myoinositol and grain yield under drought.
28 ity for the ester conjugates IAA-Glc and IAA-myoinositol and high specificity for the conjugates of i
29 al complexes of the human trimeric NCRD with myoinositol and inositol 1-phosphate showed binding of t
30 gated in symptomatic Alzheimer's disease are myoinositol and N-acetyl-aspartate.
31 a major enzyme required for the synthesis of myoinositol and the breakdown of myoinositol (1,4,5)tris
32 r a combination of dietary dexamethasone and myoinositol and the chemotherapeutic efficacy of Taxol o
33 e (Cho), N-acetyl-aspartate (NAA), creatine, myoinositol, and derived ratios were evaluated for each
34 , interconnected network with mannose (Man), myoinositol, and galacturonic acid as principal entry po
35 h various organic osmolytes, e.g., sorbitol, myoinositol, and glycerolphosphoryl-choline and H(2)O(2)
36 life MetS included citric acid, glucosamine, myoinositol, and proline (P < 0.03).
37                         Myoinositol alone or myoinositol, betaine, and taurine given sequentially inc
38                                              Myoinositol binding occurred in two major orientations,
39          In conclusion, systemic infusion of myoinositol can rapidly increase brain myoinositol conte
40        Brain metabolites (N-acetylaspartate, myoinositol, choline, creatine) were measured bilaterall
41  (the 18 kDa translocator protein, TSPO, and myoinositol) compared to pre-lockdown subjects.
42                                        Brain myoinositol content in animals with uncorrected hyponatr
43 on of myoinositol can rapidly increase brain myoinositol content, but only when plasma tonicity is co
44  quitoense) produces acylsugars containing a myoinositol core.
45   Seven SGLT isoforms (SGLT1 to 6 and sodium-myoinositol cotransporter-1, SMIT1) are known, although
46                  NAA/Cr ratios decreased and myoinositol/Cr ratios increased with age in RTT patients
47             Decreasing NAA/Cr and increasing myoinositol/Cr with age are suggestive of progressive ax
48 d for creatine, N-acetyl/creatine ratio, and myoinositol/creatine ratio in frontal white matter.
49                      Intravenous infusion of myoinositol did not alter brain water content compared w
50                                        Brain myoinositol, electrolyte, and water contents were determ
51 the cell-impermeable FGF binding antagonist, myoinositol hexakis [dihydrogen phosphate].
52 hat the AtPAP15 is a phytase that hydrolyzes myoinositol hexakisphosphate to yield myoinositol and fr
53                                    Levels of myoinositol in control conditions were also related to g
54 igated whether administration of intravenous myoinositol in rats could speed entry of the osmolyte in
55  cortex and glial activation (with increased myoinositol) in both frontal gray and white matter.
56 tyl aspartate) and glial dysfunction (higher myoinositol) in multiple brain regions.
57 concurrent infusion of hypertonic saline and myoinositol increased brain myoinositol levels by about
58 concurrent infusion of hypertonic saline and myoinositol increased brain myoinositol to levels simila
59 sorbitol pathway intermediates, depletion of myoinositol, inhibition of glycolysis, a decrease in ATP
60 ulate AsA levels by controlling the input of myoinositol into this branch of AsA biosynthesis in Arab
61                                              Myoinositol is a known precursor for AsA biosynthesis in
62 uring the production of [(3)H]IP(3) in [(3)H]myoinositol-labeled cells.
63                              The even higher myoinositol level in older adults with Down's syndrome e
64 out hypertonic saline did not increase brain myoinositol levels above control levels.
65 ly over the same time period to raise plasma myoinositol levels by 5 to 10 mM.
66 tonic saline and myoinositol increased brain myoinositol levels by about 50% above control levels.
67 e predementia phase earlier findings of high myoinositol levels in symptomatic Alzheimer's disease.
68 Significant decreases (approximately 30%) in myoinositol levels were observed in the right frontal lo
69 ine levels, on frontal gray and white matter myoinositol levels, and on the ratio of myoinositol to c
70 increase in the putative inflammation marker myoinositol (mI) and metabolic changes in total creatine
71 artate (NAA), choline (tCHO), creatine (CR), myoinositol (MI), and glutamate and glutamine (GLX) were
72  N-acetyl aspartate (NAA)/creatine (Cr), NAA/myoinositol (mI), and mI/Cr measured in the posterior ci
73                                              Myoinositol monophosphatase (IMP) is a major enzyme requ
74  administration on peripheral nerve polyols, myoinositol, Na+/K+ -ATPase, vasoactive prostaglandins,
75  rats, infusion of hypertonic saline without myoinositol or infusion of myoinositol without hypertoni
76 acid (SA)-dependent PCD, revealing roles for myoinositol or inositol derivatives in the regulation of
77 ssed by inositol phosphate turnover in [(3)H]myoinositol organ bath atrial preparations, was not incr
78 a (P < 0.001), brain water (P < 0.05), brain myoinositol (P < 0.001), and urinary phenylacetylglutami
79 rial ammonia and brain water and lower brain myoinositol (P < 0.01, respectively), compared with sham
80 at hydrolyzes 5-phosphates from a variety of myoinositol phosphate (InsP) and phosphoinositide phosph
81  function to the cell death phenotype of the myoinositol phosphate synthase1 (mips1) mutant that form
82 ne, choline, ethanolamine, glucose, lactate, myoinositol, phosphocholine, sylloinositol, and valine s
83                                          The myoinositol polyphosphate 5-phosphatases (5PTases; EC 3.
84                   By labeling the endogenous myoinositol pool in 5ptase1 and 5ptase2 mutants, we dete
85                                          The myoinositol precursor was prepared from methyl alpha-d-g
86                              Brain glutamine/myoinositol ratio was increased in the HD group but redu
87  and a significant increase in potassium and myoinositol release compared with release in hypotonic c
88 d NBD1 stability and aggregation showed that myoinositol stabilized both the Delta F508 and wild type
89                                              Myoinositol synthesis and catabolism are crucial in many
90   To determine whether the VTC4 gene impacts myoinositol synthesis in Arabidopsis, we isolated T-DNA
91 est that downstream consequences of enhanced myoinositol synthesis may underlie adjustments that coul
92 e key enzyme catalyzing the limiting step of myoinositol synthesis.
93                                          The myoinositol to creatine ratio was increased in the PPA g
94 tter myoinositol levels, and on the ratio of myoinositol to creatine.
95 tonic saline and myoinositol increased brain myoinositol to levels similar to those found in normonat
96                             In some animals, myoinositol was administered intravenously over the same
97 th muscle from six animals preloaded with 3H-myoinositol was exposed to endothelin-1, carbachol (posi
98 ic saline without myoinositol or infusion of myoinositol without hypertonic saline did not increase b